Mesothelioma, Malignant: all 418 studies
Page 2 of 5. Open to participants first (73), then studies with results posted, then the rest; newest registration first within each.
- Study of the EZH2 Inhibitor Tazemetostat in Malignant MesotheliomaCompletedNCT02860286Phase 2Results posted
- Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant MesotheliomaCompletedNCT02798536Phase 1Results posted
- Pembrolizumab in Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT02784171Phase 2/3Results posted
- Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and CisplatinCompletedNCT02709512Phase 2/3Results posted
- Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural MesotheliomaTerminatedNCT02672033Not applicableResults posted
- Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural MesotheliomaCompletedNCT02611037Phase 2Results posted
- Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)CompletedNCT02610140Phase 2Results posted
- 18F-FSPG PET/CT for Cancer Patients on TherapyCompletedNCT02599194Phase 2Results posted
- MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural MesotheliomaCompletedNCT02592551Phase 2Results posted
- Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is RecurrentCompletedNCT02568449Phase 2Results posted
- Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or CarboplatinActive, not recruitingNCT02535312Phase 1/2Results posted
- Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or MesotheliomaTerminatedNCT02408016Phase 1/2Results posted
- Pembrolizumab in Treating Patients With Malignant MesotheliomaCompletedNCT02399371Phase 2Results posted
- Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)TerminatedNCT02357147Phase 2Results posted
- Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversCompletedNCT02349412Phase 3Results posted
- A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural MesotheliomaCompletedNCT02347917Phase 1/2Results posted
- Phase II Trial of Alisertib (MLN8237) in Salvage Malignant MesotheliomaCompletedNCT02293005Phase 2Results posted
- Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma ParticipantsTerminatedNCT02004028Phase 2Results posted
- Nintedanib (BIBF 1120) in MesotheliomaTerminatedNCT01907100Phase 2/3Results posted
- Tivantinib in Treating Patients With Previously Treated Malignant MesotheliomaTerminatedNCT01861301Phase 2Results posted
- Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant MesotheliomaActive, not recruitingNCT01843374Phase 2Results posted
- Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural MesotheliomaCompletedNCT01675765Phase 1Results posted
- Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal MesotheliomaCompletedNCT01592383Phase 2Results posted
- CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic CancerTerminatedNCT01583686Phase 1/2Results posted
- SS1P and Pentostatin Plus Cyclophosphamide for MesotheliomaCompletedNCT01362790Phase 1/2Results posted
- Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality TherapyCompletedNCT01265433Phase 2Results posted
- Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)CompletedNCT01204203Phase 2Results posted
- Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With ChemotherapyCompletedNCT01160458Phase 2Results posted
- Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural MesotheliomaCompletedNCT01112293Phase 2Results posted
- NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With PemetrexedCompletedNCT01098266Phase 3Results posted
- Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line ChemotherapyCompletedNCT01085630Phase 2Results posted
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural MesotheliomaActive, not recruitingNCT01064648Phase 1/2Results posted
- Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict SensitivityCompletedNCT01024946Phase 2Results posted
- Trimodal Lung-Sparing Treatment of Pleural MesotheliomaTerminatedNCT00859495Phase 2Results posted
- Eloxatin® Plus Gemcitabine Chemotherapy for MesotheliomaCompletedNCT00859469Phase 2Results posted
- S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00770120Phase 2Results posted
- CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)TerminatedNCT00748085Not applicableResults posted
- An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural MesotheliomaCompletedNCT00738582Phase 2Results posted
- Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)CompletedNCT00700336Phase 1/2Results posted
- Phase I Dose-Escalation Study Of Azacitidine In Combination With TemozolomideCompletedNCT00629343Phase 1Results posted
- Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)TerminatedNCT00604461Phase 1/2Results posted
- An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant MesotheliomaTerminatedNCT00597116Phase 2Results posted
- Dasatinib in Treating Patients With Previously Treated Malignant MesotheliomaCompletedNCT00509041Phase 2Results posted
- Pazopanib in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00459862Phase 2Results posted
- Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaCompletedNCT00398138Phase 1Results posted
- Sunitinib in Treating Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT00392444Phase 2Results posted
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By SurgeryCompletedNCT00365053Phase 2Results posted
- Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or AbdomenCompletedNCT00316225Phase 2Results posted
- Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00309946Phase 2Results posted
- Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant MesotheliomaCompletedNCT00295503Phase 2Results posted
- S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00243074Phase 2Results posted
- Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium ThiosulfateTerminatedNCT00165503Phase 2Results posted
- Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)CompletedNCT00128102Phase 3Results posted
- Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT00101283Phase 2Results posted
- Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and ChemotherapyCompletedNCT00004547Phase 2Results posted
- Antineoplaston Therapy in Treating Patients With Advanced MesotheliomaTerminatedNCT00003508Phase 2Results posted
- Safety and Preliminary Antitumor Activity of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural MesotheliomaActive, not recruitingNCT07885306Phase 1
- From Presentation to Diagnosis: Patterns of Pleural EffusionCompletedNCT07449624
- Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage MesotheliomaWithdrawnNCT06654050Phase 2
- Immune Microenvironment and Gene Expression Profiling in MesotheliomaCompletedNCT06581549
- Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural MesotheliomaActive, not recruitingNCT06318286Phase 2
- NM32-2668 in Adult Patients With Selected Advanced Solid TumorsTerminatedNCT06299163Phase 1
- Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)Active, not recruitingNCT06155279Phase 2
- MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural MesotheliomaActive, not recruitingNCT06097728Phase 3
- A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsCompletedNCT05795595Phase 1/2
- Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural MesotheliomaCompletedNCT05660616Phase 2
- Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable CancersWithdrawnNCT05582031Phase 2
- 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsTerminatedNCT05563272Phase 2
- A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid TumorsCompletedNCT05538572Phase 1
- Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural MesotheliomaStatus unknownNCT05508555Not applicable
- Oral AMXT 1501 Dicaprate in Combination With IV DFMOTerminatedNCT05500508Phase 1/2
- Niraparib Efficacy in Patient With Unresectable MesotheliomaCompletedNCT05455424Phase 2
- Immunological Variables Associated to ICI Toxicity in Cancer PatientsStatus unknownNCT05429866Phase 2
- ......SMARTEST Trial......CompletedNCT05380713Phase 2
- Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing MesothelinWithdrawnNCT05375825Phase 1
- A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare CancersSuspendedNCT05337735Phase 2
- A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)CompletedNCT05324436
- Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)CompletedNCT05308966
- Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including MesotheliomaCompletedNCT05278975Phase 1/2
- Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the LungStatus unknownNCT05228795
- Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid TumorsTerminatedNCT05228015Phase 1
- Assessment of Histologic Prognostic Factors in Peritoneal Malignant MesotheliomaStatus unknownNCT05193006
- A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese ParticipantsCompletedNCT05136677Phase 2
- A Study of Pembrolizumab and Cryoablation in People With MesotheliomaCompletedNCT05071014Phase 1
- Real World Study of MPM in ChinaStatus unknownNCT05042557
- A Study of Pembrolizumab and Radiation Therapy in People With MesotheliomaActive, not recruitingNCT04897022Phase 1
- Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by ImmunotherapyCompletedNCT04775446
- Mesothelin-targeted CAR T-cell Therapy in Patients With MesotheliomaActive, not recruitingNCT04577326Phase 1
- Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural MesotheliomaCompletedNCT04525859Phase 1
- Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerActive, not recruitingNCT04491942Phase 1
- Intravenous Magnesium in Patients Receiving CisplatinCompletedNCT04481672Phase 1
- SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph IICompletedNCT04480372Phase 2
- Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOtheliomaStatus unknownNCT04462809Phase 2
- Cryoablation for the Promotion of Local Tumor Infiltration in Patients With MesotheliomaWithdrawnNCT04429204Not applicable
- eRAPID: Online Symptom Reporting in Lung CancerCompletedNCT04324437Not applicable
- Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid TumorsTerminatedNCT04301011Phase 1
- Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant MesotheliomaActive, not recruitingNCT04300244Phase 2
- HMPL-453 in Advanced Malignant MesotheliomaStatus unknownNCT04290325Phase 2
- Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma PatientsActive, not recruitingNCT04287829Phase 2
- A Pilot Study to Explore the Role of Gut Flora in Metastatic MesotheliomaWithdrawnNCT04214015